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Abstract Osteosarcoma is the most frequent primary
malignancy of bone, and usually metastasizes to the lung
and bones, while other sites are rare. In most reported
cases, soft tissue metastasis of osteosarcoma is unusual,
and only develops in the advanced stages of the disease,
especially following multiple recurrences. We present a
patient with recently diagnosed osteosarcoma of the right
femur, showing abdominal wall metastasis diagnosed by
technetium-99m-methylene diphosphonate (99m Tc-MDP)
whole body bone scintigraphy and confirmed histologi-
cally. The present case highlights the importance of whole
body imaging of patients with osteosarcoma for detecting
unusual sites of metastasis, especially in soft tissue organs.
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Introduction
Osteosarcoma is the most frequent primary malignancy of
bone, and usually metastasizes to the lung and bones, while
other sites are rare. In most reported cases, soft tissue
metastasis of osteosarcoma is unusual, and only develops
in the advanced stages of the disease, especially following
multiple recurrences.
We present a patient with recently diagnosed osteosar-
coma of the right femur, showing abdominal wall metastasis
diagnosed by technetium-99m-methylene diphosphonate
(99mTc-MDP) whole body bone scintigraphy and confirmed
histologically.
Case report
A 23-year-old woman with a 2-month history of right hip
pain and a recent diagnosis of osteosarcoma in the proxi-
mal right femur was referred to our department for evalu-
ation of distant bone metastasis. Her medical and family
history was unremarkable. Hematological and biochemical
tests were normal, with the exception of elevated alkaline
phosphatase and lactate dehydrogenase. She had also
undergone a computed tomography scan of the chest for
staging purposes, which revealed no abnormality. A whole
body bone scan was done 3 h after intravenous adminis-
tration of 740 MBq (20 mCi) 99m technetium methylene
diphosphonate. Bone scintigraphy demonstrated increased
radiotracer uptake in the proximal right femur, as well as in
the right sacroiliac joint and skull (Fig. 1). It also showed
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intense, abnormal extraosseous tracer uptake in the right
side of the abdomen, which persisted after the patient’s
clothes had been changed and skin washed (Fig. 2). In a
physical examination, an oval-shaped abdominal wall mass
was observed in the right periumbilical region, showing no
tenderness or erythematous change. She denied trauma or
injection at this site. An abdominal X-ray showed a focal
area with calcification in that region (Fig. 3). The patient
underwent surgical resection of the mass, and gross
examination revealed an ovoid, tan yellow, elastic-to-hard,
non-encapsulated mass measuring 4 9 3 9 2.5 cm.
Decalcified sections of the mass showed adipose tissue and
skeletal muscle fibers infiltrated by a malignant neoplasm
composed of atypical, plump, ovoid-to-spindle cells with a
high nuclear to cytoplasmic ratio (N/C ratio), hyperchro-
matic nuclei, and prominent nucleoli resting in a chondroid
matrix with foci of partially mineralized, lace-like, osteoid
matrix (Fig. 4). The findings were diagnostic for high-
grade osteosarcoma, and were morphologically similar to
the patient’s primary bone osteosarcoma and consistent
with metastatic focus of osteosarcoma.
Discussion
Approximately, 20 % of patients with osteosarcoma have
distant metastasis at diagnosis, which is an extremely poor
prognostic finding. The lung is the most common site,
followed by the bone [1]. The occurrence of extrapulmo-
nary soft tissue metastasis appears to be extremely rare,
and is typically seen in the advanced stages [2]. Aggressive
treatment with surgery and intensified chemotherapy have
altered the pattern of metastatic recurrences in patients
treated for osteosarcoma, and a higher rate of atypical
extrapulmonary locations for metastasis is being reported
[3], including lymph nodes, brain, small bowel, pancreas,
kidney, peritoneum, pleura, breast, skin, and subcutaneous
fat [2, 4–6]. There are also some limited reports of skeletal
muscle [7, 8] and abdominal wall metastasis of osteosar-
coma [9, 10]. Although skeletal muscle comprises about
40 % of total body mass and is a highly vascularized tissue,
the frequency of intramuscular metastasis is just 0.8 %.
The rarity of metastasis in skeletal muscle can be explained
by various cellular and molecular mechanisms in the host
environment, which inhibit growth and metastasis of
tumors and make skeletal muscle a hostile milieu for the
proliferation of malignant cells [11]. Likewise, some
Fig. 1 Whole body bone scintigraphy using 99m technetium
methylene diphosphonate demonstrated increased radiotracer uptake
in the proximal right femur, as well as in the right sacroiliac joint and
skull





uptake in the right side of the
abdomen, which persisted after
the patient’s clothes had been
changed and skin washed
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evidences demonstrated a mechanism whereby muscular
system puts forth three certain inhibitory effects upon
metastatic cell which are (1) cellular recruitment into the
myogenic lineage, (2) a paracrine-mediated cytostatic and
(3) paracrine-mediated cytotoxic response [12].
In almost all reported cases, unusual metastatic sites
have appeared as tumor recurrence at least several months
after initial treatment. However, in this patient, who was
newly diagnosed and previously untreated, metastasis was
identified in the abdominal wall. Furthermore, this case
describes an unusual metastatic pattern, whereby osteo-
sarcoma preferred the soft tissue to the lung, which is the
most common metastatic site. Our case highlights the
importance of whole body imaging of patients with oste-
osarcoma for detecting unusual sites of metastasis, espe-
cially in soft tissue organs. Physicians should also be aware
of changing patterns of metastasis in patients with
osteosarcoma.
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Fig. 3 Abdominal X-ray showed a focal area with calcification in
the right side of the abdomen
Fig. 4 Microscopic view (H&E, 4009) of the malignant osteoblasts
infiltrating the skeletal muscle fibers of the abdominal wall (arrow)
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